http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10952803-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14c7be3b2483fb8a27be02b0b1269e20
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2034-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2560-063
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-0891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-504
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B34-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-4258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1827
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B34-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
filingDate 2015-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fd89d155fa823a86cb8356a4107077f
publicationDate 2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10952803-B2
titleOfInvention Methods and apparatus for dipole field navigation for direct targeting of therapeutic agents
abstract A method for navigating therapeutic, diagnostic or imaging agents in a vascular network or body cavity is introduced. The method is characterized by high directional gradients and a high magnetic field strength. The latter is used to saturate the magnetization of magnetic therapeutic agents such that when combined with high directional gradients, improved navigation of the magnetic therapeutic agents can be provided at various depths within a patient's body.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11657940-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2023145528-A1
priorityDate 2014-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007231393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013046169-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504175

Total number of triples: 39.